SEC Form 4 · accession 0001193125-26-335605
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Douglas Lyon
Officer — See Remarks
Period of report
Aug 3, 2026
Accepted (ET)
Aug 5, 2026 · 5:48 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 3, 2026 | S | 1,540 | $114.16 | D | 5,495 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 537 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
Remarks
Chief Accounting & Technology Officer